e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
The prognostic value of cardiopulmonary exercise testing
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis
K. Flaherty (Ann Arbour, United States of America)
Source:
Annual Congress 2011 - The prognostic value of cardiopulmonary exercise testing
Session:
The prognostic value of cardiopulmonary exercise testing
Session type:
Symposium
Number:
1852
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Flaherty (Ann Arbour, United States of America). The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis. Annual Congress 2011 - The prognostic value of cardiopulmonary exercise testing
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
PG16 Advanced cardiopulmonary exercise testing
Measurement properties of field walking tests in chronic respiratory diseases
Related content which might interest you:
Cardiopulmonary exercise test as prognostic tool in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2007 - Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases
Year: 2007
The prognostic significance of cardiopulmonary exercise in IPF
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011
Relationship of cardiopulmonary exercise testing (CPET) and lung function in idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2007; 30: Suppl. 51, 120s
Year: 2007
Concurrent validity among three field tests and the cardiopulmonary exercise testing in patients with idiopathic pulmonary fibrosis.
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020
The value of cardiopulmonary exercise test in assessment of the severity of pulmonary arterial hypertension patients
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017
The role of cardiopulmonary exercise test in identifying pulmonary veno-occlusive disease
Source: Eur Respir J, 57 (6) 2100115; 10.1183/13993003.00115-2021
Year: 2021
The sPAP/VO2 ratio during cardiopulmonary exercise testing as predictor of manifest pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Year: 2012
Pulmonary function and cardiopulmonary exercise tests in patients with bronchiectasis
Source: Annual Congress 2010 - Exercise in healthy and non-respiratory diseases
Year: 2010
Cardiopulmonary exercise test to predict pulmonary rehabilitation outcome in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2017 – Latest insights into functional capacity, muscle weakness and physical activity in chronic lung diseases
Year: 2017
Endurance time is the most sensitive exercise measurement for evaluating pulmonary rehabilitation efficacy in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2012 - The latest insights in pulmonary rehabilitation
Year: 2012
Value of cardiopulmonary exercise testing in interstitial lung diseases
Source: International Congress 2018 – New methods and concepts in exercise testing
Year: 2018
Cardiopulmonary exercise testing in patients with severe pulmonary hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 489s
Year: 2001
Value of maximal and submaximal variables during incremental cardiopulmonary exercise testing to predict survival in pateints with pulmonary arterial hypertension (PAH)
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
The prognostic role of cardiopulmonary exercise testing in disease
Source: International Congress 2018 – PG16 Advanced cardiopulmonary exercise testing
Year: 2018
The prognostic role of cardiopulmonary exercise testing in disease
Source: International Congress 2019 – PG3 Advanced cardiopulmonary exercise testing
Year: 2019
Cardiopulmonary exercise testing in interstitial lung diseases and the value of ventilatory efficiency
Source: Eur Respir Rev, 30 (162) 200355; 10.1183/16000617.0355-2020
Year: 2021
Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension
Source: Eur Respir J 2012; 40: 1410-1419
Year: 2012
The prognostic value of cardiopulmonary exercise testing in interstitial lung disease: a systematic review
Source: ERJ Open Res, 6 (3) 00027-2020; 10.1183/23120541.00027-2020
Year: 2020
Exertional dyspnoea in interstitial lung diseases: the clinical utility of cardiopulmonary exercise testing
Source: Eur Respir Rev 2017; 26: 160099
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept